Cargando…
A COVID-19 patient with recurrent acute limb ischaemia despite two successive types of therapeutic dose anticoagulation and thrombolysis
COVID-19 is caused by the SARS-CoV-2, and its presentation ranges from mild upper respiratory illness to critical disease including acute respiratory distress syndrome and multiorgan dysfunction. While it was initially believed to primarily target the respiratory system, numerous studies have demons...
Autores principales: | Teng, Eva, Pignanelli, Marcelle, Hammad, Faiza, Wisa, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365780/ https://www.ncbi.nlm.nih.gov/pubmed/34389601 http://dx.doi.org/10.1136/bcr-2021-245040 |
Ejemplares similares
-
Progressive COVID-19-Associated Coagulopathy Despite Treatment with Therapeutic Anticoagulation and Thrombolysis
por: Aribawa, I. Gusti Ngurah Mahaalit, et al.
Publicado: (2021) -
Thrombosis of pulmonary vasculature despite anticoagulation and thrombolysis: The findings from seven autopsies
por: Porembskaya, O., et al.
Publicado: (2020) -
Successful Thrombolysis despite Having an Incidental Unruptured Cerebral Aneurysm
por: Briosa e Gala, Diana, et al.
Publicado: (2014) -
Outcome and complications after intra-arterial thrombolysis for lower limb ischaemia with or without continuous heparin infusion
por: Grip, O, et al.
Publicado: (2014) -
Acute limb ischemia in COVID-19 patients despite therapeutic anticoagulation: Experience from Africa
por: Alemayehu, Fikremariam Melkeneh, et al.
Publicado: (2023)